Abivax S.A. Gains On Change In Fair Value Of Derivatives
Abivax S.A. (ABVX) reported Gains On Change In Fair Value Of Derivatives of EUR 3.62 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Income Statement › Other Income
ifrs-full:GainsOnChangeInFairValueOfDerivatives · last filed 2026-03-23
- Abivax S.A. gains on change in fair value of derivatives for the quarter ending 2025-12-31 was 0.00 EUR, a 100.00% decline year-over-year.
- Abivax S.A. gains on change in fair value of derivatives for the quarter ending 2025-09-30 was 3.64M EUR, a 220.05% increase year-over-year.
- Abivax S.A. gains on change in fair value of derivatives for the quarter ending 2025-06-30 was 156.00K EUR, a 49.02% decline year-over-year.
- Abivax S.A. gains on change in fair value of derivatives for the quarter ending 2025-03-31 was 145.00K EUR.
| Period end | Gains On Change In Fair Value Of Derivatives 3 month | Gains On Change In Fair Value Of Derivatives 6 month | Gains On Change In Fair Value Of Derivatives 9 month | Gains On Change In Fair Value Of Derivatives 12 month |
|---|---|---|---|---|
| 2025-12-31 | 0.00 EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-23 | 3.64M EUR derived: sum of 2 quarters · filed 2026-03-23 | 3.79M EUR derived: sum of 3 quarters · filed 2026-03-23 | 3.62M EUR 20-F · filed 2026-03-23 |
| 2025-09-30 | 3.64M EUR 6-K · filed 2025-12-15 | 3.79M EUR derived: sum of 2 quarters · filed 2025-12-15 | 3.62M EUR 6-K · filed 2025-12-15 | 5.21M EUR derived: sum of 4 quarters · filed 2026-03-23 |
| 2025-06-30 | 156.00K EUR 6-K · filed 2025-09-08 | 72.00K EUR 6-K · filed 2025-09-08 | 1.57M EUR derived: sum of 3 quarters · filed 2026-03-23 | 2.71M EUR derived: sum of 4 quarters · filed 2026-03-23 |
| 2025-03-31 | 145.00K EUR 6-K · filed 2025-06-02 | 1.42M EUR derived: sum of 2 quarters · filed 2026-03-23 | 2.56M EUR derived: sum of 3 quarters · filed 2026-03-23 | 2.86M EUR derived: sum of 4 quarters · filed 2026-03-23 |
| 2024-12-31 | 1.27M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-23 | 2.41M EUR derived: sum of 2 quarters · filed 2026-03-23 | 2.72M EUR derived: sum of 3 quarters · filed 2026-03-23 | 1.41M EUR 20-F · filed 2026-03-23 |
| 2024-09-30 | 1.14M EUR 6-K · filed 2025-12-15 | 1.44M EUR derived: sum of 2 quarters · filed 2025-12-15 | 139.00K EUR 6-K · filed 2025-12-15 | |
| 2024-06-30 | 306.00K EUR 6-K · filed 2025-09-08 | 27.00K EUR 6-K · filed 2025-09-08 | ||
| 2024-03-31 | 0.00 EUR 6-K · filed 2025-06-02 | |||
| 2023-12-31 | 1.01M EUR 20-F · filed 2026-03-23 | |||
| 2022-12-31 | 9.37M EUR 20-F · filed 2025-03-24 | |||
| 2021-12-31 | 2.42M EUR 20-F · filed 2024-04-05 |